CFO Antonio Zamora Galland stated that the financing serves the company's broader strategy to bolster its working capital management and maintain a stable financial foundation for future business growth. The deal marks a significant step in the company's efforts to manage its liabilities amid its ongoing expansion in the Latin American pharmaceutical and personal care markets.
In section Releases
Genomma Lab Secures MXN 1 Billion Credit Facility from Banamex
Mexico City-based Genomma Lab Internacional has finalized a three-year, MXN 1 billion credit facility with Banamex to restructure its balance sheet. The pharmaceutical firm intends to use the capital to prepay existing bank loans and address upcoming maturities of its outstanding certificates, effectively optimizing its long-term debt profile.
Jorge Rohana de la Vega, Corporate Director at Banamex, emphasized that the partnership aligns with the bank's commitment to supporting the growth of domestic companies across various sectors. Genomma Lab, which trades on the Mexican Stock Exchange under the ticker LABB, continues to operate its unique model of consumer-oriented marketing and a flexible, low-cost supply chain.
Comments (0)
No comments yet. Be the first!